December 1: Key Developments-Genomics in Mesothelioma Cases

Join us for this complimentary CLE webinar on Thursday, December 1, 2022 from 1:30-2:45 pm ET.
Topics for discussion include:

• Key Litigation Developments
• Genomic Data Increasingly Found in Medical Records
• Dr. Testa’s Acknowledgement that Whole Genome Sequencing is Best and Mutations Cannot Be Predicted
• Concessions that Some BAP1 Mutations Can By Themselves Cause Mesotheliomas and Other Cancers
• Developments in Alameda County Regarding Genetic Testing
• Key Scientific Developments
• Key Points from Carbone 2022 on BAP1 Null Variants
• Examples of Null BAP1 Variants in Mesotheliomas
• Roles of BAP1 Protein
• Tissue Specific Effects Can Explain the Resulting Cancer(s)
• Key Applications and Uses of Genomic Data
• Differences Between WGS and WES
• Understanding Limits of Gene Panels
• Uses of Both Somatic and Germline Mutation Data
• Applications Extend Beyond Mesothelioma.

Title:

Key Developments-Genomics in Mesothelioma Cases

Date+Time:
December 1, 2022

1:30-2:45 p.m. ET

Register Now for this free Continuing Legal Education Webinar!
Speakers:

• Kirk T. Hartley, Principal at LSP Group and ToxicoGenomica
• Leonel van Zyl, PhD., ToxicoGenomica, CEO, ArrayXpress Inc.
• Michael Zapata III, Executive Chairman, ArrayXpress, Inc. and Protochips Inc.

CLE Credit:

California, Illinois, New Jersey, New York, Pennsylvania, Texas, and Washington.

By:

Perrin Conferences.

More Information And Registration